|
" Venture investing in science / "
Douglas W. Jamison and Stephen R. Waite ; foreword by Mark Anderson.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
876661
|
| Main Entry
|
:
|
Jamison, Douglas W.
|
| Title & Author
|
:
|
Venture investing in science /\ Douglas W. Jamison and Stephen R. Waite ; foreword by Mark Anderson.
|
| Publication Statement
|
:
|
New York :: Columbia University Press,, [2017]
|
| Series Statement
|
:
|
Columbia Business School Publishing
|
| Page. NO
|
:
|
1 online resource (xvii, 280 pages) :: illustrations
|
| ISBN
|
:
|
0231544707
|
|
|
:
|
: 9780231544702
|
|
|
:
|
0231175728
|
|
|
:
|
9780231175722
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Introduction -- Deep science disruption -- The U.S. deep science innovation ecosystem -- Deep science and the evolution of American venture capital -- Diversity breakdown in venture investing -- Fostering diversity in venture investing -- Deep science venture investing -- Our choice ahead -- Appendix 1. The case of D-wave systems -- Appendix 2. The case of Nantero.
|
| Abstract
|
:
|
Over the past decade, software companies have increasingly monopolized the flow of venture capital, starving support for scientific research and its transformative discoveries. New medicines, cheaper and faster personal computers, and other life-changing developments all stem from investment in science. In the past, these funds led to steam engines, light bulbs, microprocessors, 3D printers, and even the Internet. In Venture Investing in Science, the venture capitalist Douglas W. Jamison and the investment author Stephen R. Waite directly link financial support to revolutionary advancements in physics, computers, chemistry, and biology and make a passionate case for continued investing in science to meet the global challenges of our time. Clean air and water, cures for intractable diseases, greener public transportation, cheaper and faster communication technologies--these are some of the rich opportunities awaiting venture capital investment today. Jamison and Waite focus on how early-stage companies specializing in commercializing transformative technologies based on deep science have been shunned by venture capitalists, and how the development of such companies have been hampered by structural changes in capital markets and government regulation over the past decade. The authors argue that reinvigorating science-based technological innovation is crucial to reactivating the economic dynamism that lifts living standards and fuels prosperity over time.
|
| Subject
|
:
|
New business enterprises-- United States-- Finance.
|
| Subject
|
:
|
Science and industry-- United States.
|
| Subject
|
:
|
Venture capital-- United States.
|
| Subject
|
:
|
BUSINESS ECONOMICS-- Finance.
|
| Subject
|
:
|
Investitionsentscheidung
|
| Subject
|
:
|
Neue Technologie
|
| Subject
|
:
|
New business enterprises-- Finance.
|
| Subject
|
:
|
Risikokapital
|
| Subject
|
:
|
Science and industry.
|
| Subject
|
:
|
SCIENCE-- Applied Sciences.
|
| Subject
|
:
|
Venture capital.
|
| Subject
|
:
|
United States.
|
| Dewey Classification
|
:
|
332.6
|
| LC Classification
|
:
|
HG4751
|
| Added Entry
|
:
|
Waite, Stephen R.
|
| |